Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Genprex announces promising results for Oncoprex in Phase II lung cancer trial Texas-based biopharmaceutical company Genprex has unveiled positive interim data from an ongoing phase II clinical trial, NCT01455389, for… bypharmanewsdailyJanuary 7, 2017